![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Dirk Deleu
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.21, Iss.11, 2004-01, pp. : 687-709
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rasagiline in the pharmacotherapy of Parkinson’s disease – a review
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gene therapy for Parkinson’s disease: review and update
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. :